Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patients

European Journal of Cancer

Volumn 50, Issue 12, 2014, Pages 2134-2141

  Muendlein, Axel ^a,c   Hubalek, Michael ^e   Geller Rhomberg, Simone ^a,c   Gasser, Klaus ^a,b,c   Winder, Thomas ^a,b,c   Drexel, Heinz ^a,b,c   Decker, Thomas ^d   Mueller Holzner, Elisabeth ^e   Chamson, Martina ^e   Marth, Christian ^e   Lang, Alois H ^a,b  

^a Vorarlberg Institute for Vascular Investigation and Treatment   (Austria)

^b ACADEMIC TEACHING HOSPITAL FELDKIRCH   (Austria)

^c PRIVATE UNIVERSITY OF THE PRINCIPALITY OF LIECHTENSTEIN   (Liechtenstein)

^d Studienzentrum Onkologie Ravensburg   (Germany)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Breast neoplasms; MACC1; Polymorphism; Single nucleotide; Survival

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; METASTASIS ASSOCIATED IN COLON CANCER 1 PROTEIN; ONCOPROTEIN; TRASTUZUMAB; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; EVENT FREE SURVIVAL; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL;

BREAST NEOPLASMS; MACC1; POLYMORPHISM; SINGLE NUCLEOTIDE; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECEPTOR, ERBB-2; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS;

EID: 84903991659     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.05.007     Document Type: Article

References (40)

1. G. Christofori New signals from the invasive front Nature 441 2006 444 450
2. C. Birchmeier, W. Birchmeier, E. Gherardi, and G.F. Vande Woude Met, metastasis, motility and more Nat Rev Mol Cell Biol 4 2003 915 925
3. C. Boccaccio, and P.M. Comoglio Invasive growth: a MET-driven genetic programme for cancer and stem cells Nat Rev Cancer 6 2006 637 645
4. G.H. Xiao, M. Jeffers, A. Bellacosa, Y. Mitsuuchi, G.F. Vande Woude, and J.R. Testa Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways Proc Natl Acad Sci U S A 98 2001 247 252
5. C. Ponzetto, A. Bardelli, and Z. Zhen et al. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family Cell 77 1994 261 271
6. I.M. Seiden-Long, K.R. Brown, and W. Shih et al. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer Oncogene 25 2006 91 102
7. V. Brinkmann, H. Foroutan, M. Sachs, K.M. Weidner, and W. Birchmeier Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells J Cell Biol 131 1995 1573 1586
8. F. Silvagno, A. Follenzi, and M. Arese et al. In vivo activation of met tyrosine kinase by heterodimeric hepatocyte growth factor molecule promotes angiogenesis Arterioscler Thromb Vasc Biol 15 1995 1857 1865
9. M. Stoker, E. Gherardi, M. Perryman, and J. Gray Scatter factor is a fibroblast-derived modulator of epithelial cell mobility Nature 327 1987 239 242
10. K.P. Raghav, W. Wang, and S. Liu et al. CMET and phospho-cMET protein levels in breast cancers and survival outcomes Clin Cancer Res 18 2012 2269 2277
11. L. Beviglia, K. Matsumoto, C.S. Lin, B.L. Ziober, and R.H. Kramer Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression Int J Cancer 74 1997 301 309
12. S. Agarwal, C. Zerillo, and J. Kolmakova et al. Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells Br J Cancer 100 2009 941 949
13. K. Sawada, A.R. Radjabi, and N. Shinomiya et al. C-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion Cancer Res 67 2007 1670 1679
14. K. Taniguchi, Y. Yonemura, and N. Nojima et al. The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor Cancer 82 1998 2112 2122
15. U.S. Kammula, E.J. Kuntz, and T.D. Francone et al. Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome Cancer Lett 248 2007 219 228
16. G. Minuti, F. Cappuzzo, and R. Duchnowska et al. Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer Br J Cancer 107 2012 793 799
17. U. Stein, W. Walther, and F. Arlt et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis Nat Med 15 2009 59 67
18. U. Stein, J. Smith, W. Walther, and F. Arlt MACC1 controls Met: what a difference an Sp1 site makes Cell Cycle 8 2009 2467 2469
19. A. Shirahata, M. Sakata, and Y. Kitamura et al. MACC 1 as a marker for peritoneal-disseminated gastric carcinoma Anticancer Res 30 2010 3441 3444
20. L. Wang, Y. Wu, and L. Lin et al. Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion Int J Cancer 133 2013 1419 1430
21. H. Shimokawa, H. Uramoto, and T. Onitsuka et al. Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence J Thorac Cardiovasc Surg 141 2011 895 898
22. Y.P. Yang, J.H. Qu, and X.J. Chang et al. High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma J Transl Med 11 2013 41
23. Y. Huang, H. Zhang, and J. Cai et al. Overexpression of MACC1 and its significance in human breast cancer progression Cell Biosci 3 2013 16
24. A.H. Lang, S. Geller-Rhomberg, and T. Winder et al. A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients BMC Cancer 12 2012 20
25. Z. Zheng, S. Gao, and Z. Yang et al. Single nucleotide polymorphisms in the metastasis-associated in colon cancer-1 gene predict the recurrence of hepatocellular carcinoma after transplantation Int J Med Sci 11 2014 142 150
26. U. Stein, M. Dahlmann, and W. Walther MACC1 - more than metastasis? Facts and predictions about a novel gene J Mol Med 88 2010 11 18
27. Edge SB, Byrd DR, Compton CC. AJCC Cancer Staging Manual. ed 7. Chicago, IL: Springer; 2009.
28. W.D. Dupont, and W.D. Plummer Jr Power and sample size calculations. A review and computer program Control Clin Trials 11 1990 116 128
29. P. Kumar, S. Henikoff, and P.C. Ng Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm Nat Protoc 4 2009 1073 1081
30. I.A. Adzhubei, S. Schmidt, and L. Peshkin et al. A method and server for predicting damaging missense mutations Nat Methods 7 2010 248 249
31. G. Edakuni, E. Sasatomi, T. Satoh, O. Tokunaga, and K. Miyazaki Expression of the hepatocyte growth factor/c-Met pathway is increased at the cancer front in breast carcinoma Pathol Int 51 2001 172 178
32. S. Garcia, J.P. Dales, and E. Charafe-Jauffret et al. Overexpression of c-Met and of the transducers PI3K, FAK and JAK in breast carcinomas correlates with shorter survival and neoangiogenesis Int J Oncol 31 2007 49 58
33. S. Garcia, J.P. Dales, and E. Charafe-Jauffret et al. Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype Hum Pathol 38 2007 830 841
34. H. Khoury, M.A. Naujokas, and D. Zuo et al. HGF converts ErbB2/Neu epithelial morphogenesis to cell invasion Mol Biol Cell 16 2005 550 561
35. D.L. Shattuck, J.K. Miller, K.L. Carraway 3rd, and C. Sweeney Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells Cancer Res. 68 2008 1471 1477
36. G.R. Blumenschein Jr., G.B. Mills, and A.M. Gonzalez-Angulo Targeting the hepatocyte growth factor-cMET axis in cancer therapy J Clin Oncol 30 2012 3287 3296
37. F. Cecchi, D.C. Rabe, and D.P. Bottaro Targeting the HGF/Met signalling pathway in cancer Eur J Cancer 46 2010 1260 1270
38. F. Galimi, D. Torti, and F. Sassi et al. Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations Clin Cancer Res 17 2011 3146 3156
39. F. Schmid, S. Burock, K. Klockmeier, P.M. Schlag, and U. Stein SNPs in the coding region of the metastasis-inducing gene MACC1 and clinical outcome in colorectal cancer Mol Cancer 11 2012 49
40. A. Goldhirsch, W.C. Wood, A.S. Coates, R.D. Gelber, B. Thurlimann, and H.J. Senn Strategies for subtypes - dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Ann Oncol 22 2011 1736 1747